Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC391742 Inhibitors

Chemical inhibitors of LOC391742 can modulate the activity of this protein through various signaling pathways by targeting specific kinases and enzymes involved in cellular processes. Alsterpaullone, as a cyclin-dependent kinase inhibitor, disrupts the function of CDK5, which may be a key regulator in the pathways where LOC391742 is active. This disruption alters the phosphorylation state and activity of proteins within these pathways, leading to a functional inhibition of LOC391742. Similarly, Rapamycin acts on the mTOR pathway, a pivotal mechanism for cell growth and survival, thus decreasing the activity of proteins that interact with or regulate LOC391742. LY294002 and Wortmannin, both PI3K inhibitors, lead to a reduction in AKT activation, which is crucial for downstream signaling events. This reduction ultimately interferes with the phosphorylation and activation of proteins, including potentially LOC391742, thereby curtailing its activity.

Further inhibitors such as SB203580 and SP600125 target the p38 MAP kinase and JNK, respectively, both of which are part of the MAPK signaling cascade. SB203580's action on the p38 MAPK impedes stress response signaling that may be necessary for LOC391742 function, while SP600125's inhibition of JNK could disrupt apoptosis regulation and other cellular processes related to LOC391742. PD98059 and U0126, both MEK inhibitors, prevent the activation of the MAPK/ERK pathway, which is essential for cell proliferation and differentiation; this prevention could lead to the functional inhibition of LOC391742. ZM336372, which inhibits RAF kinase activity, and BAY 11-7082, which inhibits NF-κB activation, both contribute to the functional inhibition of LOC391742 by disrupting signaling processes that are crucial for the protein's activity. Lastly, Gö6983 targets PKC isozymes that may regulate LOC391742, and Dorsomorphin inhibits BMP signaling that LOC391742 could be a part of, both resulting in the modulation of LOC391742 activity through their respective pathways.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$68.00
$312.00
2
(1)

Alsterpaullone inhibits cyclin-dependent kinases such as CDK5, which is involved in neuronal signaling pathways. Inhibition of CDK5 by Alsterpaullone can lead to the functional inhibition of LOC391742 by altering the phosphorylation state and activity of proteins within the pathways where LOC391742 operates, assuming LOC391742 is regulated by CDK5 activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits the mTOR pathway, which is crucial for cell growth and survival signaling. The inhibition of mTOR can lead to a decrease in the translation and activity of proteins associated with this pathway, thereby functionally inhibiting LOC391742, provided LOC391742 is downstream of or regulated by mTOR signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can hinder the PI3K/AKT pathway. By inhibiting PI3K, LY294002 can suppress AKT activation, leading to reduced phosphorylation and activation of downstream proteins. This can functionally inhibit LOC391742 by impairing the signaling cascade it is part of, thereby affecting its activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin also inhibits PI3K, leading to a blockade of the PI3K/AKT pathway. The inhibition of this pathway can decrease the phosphorylation of target proteins and effectively inhibit LOC391742's activity by disrupting the cellular processes in which it is involved.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAP kinase inhibitor that can disrupt the p38 MAPK signaling pathway. The inhibition of p38 MAPK can lead to reduced activation of downstream proteins that are essential for stress responses and, potentially, the functional activity of LOC391742, provided that LOC391742 is a part of this signaling pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of JNK, which is part of the MAPK signaling cascade. By inhibiting JNK activity, SP600125 can interfere with apoptosis regulation and other cellular processes, potentially leading to functional inhibition of LOC391742, assuming LOC391742's activity is modulated by JNK signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a MEK inhibitor that can prevent the activation of the MAPK/ERK pathway. This inhibition can functionally inhibit LOC391742 by impeding the phosphorylation and activation of proteins within the pathway, assuming LOC391742 relies on MEK signaling for its activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 specifically inhibits MEK1/2, leading to suppression of the MAPK/ERK pathway. The inhibition of MEK1/2 and subsequent reduction of ERK activity can result in the functional inhibition of LOC391742 by disrupting its role in cell proliferation and differentiation processes.

ZM 336372

208260-29-1sc-202857
1 mg
$47.00
2
(1)

ZM336372 is a RAF kinase inhibitor that can inhibit the MAPK/ERK pathway upstream. The functional inhibition of LOC391742 can be achieved by ZM336372 through the disruption of RAF kinase activity, assuming LOC391742's function is dependent on signals propagated through RAF kinases.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

BAY 11-7082 inhibits NF-κB activation, which can lead to the functional inhibition of LOC391742 by impeding the signaling processes that rely on NF-κB for transcriptional activation of proteins involved in inflammation and cell survival, assuming LOC391742 is associated with such processes.